Declines in anogenital wart rates among young people are most likely because of the human papillomavirus vaccine
, according to a new study.
FDA licensure of bivalent human papillomavirus vaccine
(HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).
From 1st April, the human papillomavirus vaccine
is being offered to all MSM up to 45 years of age who attend sexual health clinics.
Vaccines like the human papillomavirus vaccine
also assist in preventing cervical cancer.
Are there socioeconomic disparities in women having discussions on human papillomavirus vaccine
with health care providers?
The increased risk was present only for subjects who received a concomitant vaccine along with the MenACWY-CRM, such as Tdap, influenza, or human papillomavirus vaccine
American College of Pediatricians New Concerns about the Human Papillomavirus Vaccine
Human Papillomavirus Vaccine
Acceptance among Commuter College Students: The Role of Health Insurance Coverage.
Adverse reactions to human papillomavirus vaccine
in the Valencian Community (2007-2011).
One or two doses of the bivalent human papillomavirus vaccine
provide a level of protection against cervical HPV infection similar to that of the full three-dose schedule, according to post hoc analysis from two phase III, double-blind, randomized controlled trials with 4 years follow-up.
Recommendations on the use of quadrivalent human papillomavirus vaccine
in males-Advisory Committee on Immunization Practices (ACIP), 2011.
Japan-based Takeda Pharmaceutical has transferred its license agreement with the Japan Health Sciences Foundation for worldwide patent rights of a human papillomavirus vaccine
to the Chemo-Sero-Therapeutic Research Institute (Kaketsuken), it was reported yesterday.